MedPath

Early Oral Nutrition in Mild Acute Pediatric Pancreatitis

Not Applicable
Terminated
Conditions
Acute Pediatric Pancreatitis
Interventions
Dietary Supplement: Early Oral Nutrition
Registration Number
NCT01423786
Lead Sponsor
Nationwide Children's Hospital
Brief Summary

This is a prospective trial for children with the diagnosis of mild acute pancreatitis admitted to the hospital for continued management. Patients will be enrolled in the study within 24 hours of admission/diagnosis and will be allowed an oral diet once enrolled. Demographic, laboratory and imaging data done as standard of care will be collected and additional blood work will be sent as part of the study. Patients will be followed prospectively with regards to tolerance to oral nutrition, pain, length of stay and complications. The hypothesis is that patients that are able to tolerate early oral nutrition will have shorter length of stays and will be similar in terms of pain score ratings, readmission rates, complications and the need for invasive supplemental nutrition. Also patients that are able to tolerate early oral nutrition will have less significant elevation of biochemical markers of pancreatitis severity when compared to patients that do not tolerate early oral nutrition and historical controls.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Diagnosis of acute pancreatitis
  • Enroll within 24 hours of diagnosis
  • At least 50% of baseline diet must be taken orally
Exclusion Criteria
  • Evidence of severe pancreatitis
  • Diagnosis of chronic pancreatitis
  • Patients unable to communicate pain or a desire to eat/drink

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Please helpEarly Oral NutritionDr. Kumar left Nationwide Children's Hospital in 2014 and efforts to get ahold of her to complete her ct.gov entries have been unsuccessful as we are not able to get ahold of her. In July 2014, she wrote in her Continuing Review application to the NCH IRB: "34 patients have been recruited and data has mostly been collected. Follow up calls have been made and no adverse events occurred during the study period." No other information is available.
Primary Outcome Measures
NameTimeMethod
Tolerance of Oral Nutrition1 week

The time it takes for the patient to tolerate at least 50% of his/her goal oral calories while maintaining hydration as assessed by urine ouput or fluid intake

Secondary Outcome Measures
NameTimeMethod
Length of Stay1 week

The length of time between admission for acute pancreatitis and discharge.

Trial Locations

Locations (1)

Nationwide Children's Hospital

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath